Structural bases of vasopressin/oxytocin receptor function
Open accessAbstract
The neurohypophyseal hormones vasopressin and oxytocin are two closely related nonapeptides, synthesized mainly by the magnocellular neurons of the hypothalamus. Their peptide sequences differ only in the amino acids at positions 3 and 8, but, for both hormones, the formation of a disulfide bond between Cys residues at the 1 and 6 positions results in a peptide constituted of a 6 amino acid cyclic part and a 3 amino acid C-terminal part. Both peptides exert various hormonal effects. Circulating oxytocin is mostly known for its ability to elicit the contraction of uterine smooth muscle at term and that of myoepithelial cells that surround the alveoli of the mammary gland during lactation. The main endocrine functions of arginine vasopressin (AVP) are the facilitation of water reabsorption by the kidney and the contraction of smooth muscle cells in arteries. AVP released in the portal blood in the median eminence acts as a potent secretagogue of adrenocorticotropin. In addition, it has become clear that vasopressin and oxytocin, besides mediating well-documented functions at the periphery, are also critically involved in numerous central processes including higher cognitive functions such as memory and learning (see Barberis & Tribollet 1996 for review). Vasopressin and oxytocin were the first biologically active peptides to be synthesized. This achievement, by Du Vigneaud and coworkers, 40 years ago, ushered in the modern era of peptide chemistry. During the subsequent decades, many structural analogues of the neurohypophyseal hormones have been synthesized and pharmacologically characterized (Manning & Sawyer 1993). Peripheral vasopressin and oxytocin receptors have been classified on the basis of both the second messenger system coupled to the receptors and the affinity of a series of vasopressin and oxytocin analogues with enhanced selectivity for a certain receptor type. These classification criteria have led to the distinction of V1a vasopressin (liver, smooth muscle cells from blood vessels, and most peripheral tissues expressing vasopressin receptors), V1b vasopressin (adenohypophysis), V2 vasopressin (kidney) and oxytocin (uterus, mammary gland) receptors ( Jard et al. 1988). To date central receptors have been identified as being of the vasopressin V1a and oxytocin subtypes. Moreover, a great number of molecular probes have been developed, including agonists and antagonists, and radiolabelled, fluorescent or photosensitive ligands. These make this receptor family a good model with which to study structure–function relationships. Today, the four different receptor subtypes have been cloned in mammals, lower vertebrates and invertebrates. Molecular cloning studies have renewed interest in these neurohormone receptors. Vasopressin V1b receptor mRNA has been detected in peripheral tissues (kidney, thymus, heart, lung, spleen, uterus and breast) and numerous areas of the brain in the rat (Lolait et al. 1995), and this receptor subtype has also been characterized in rat adrenal (Grazzini et al. 1996). These studies suggest that the vasopressin V1b receptor may serve additional and unknown functions in the brain and at the periphery. The primary focus of this review is to summarize recent studies that have led to novel insights into the molecular bases of vasopressin and oxytocin receptor functions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Most critical sites for AVP-V1aR binding are conserved, with one notable exception.
“Like the OTR, most of the critical sites for AVPV1aR binding are conserved (Barberis et al., 1998; Chini et al., 1995; Mouillac et al., 1995; Thibonnier et al., 2000), with one notable exception.”
From Neuropeptide diversity and the regulation of social behavior in New World primates (2016) · cites this paper as Barberis et al., 1998
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Proceedings of the National Academy of Sciences, USA.
Ochoa, S. (1996) · Current Biology · doi:10.1016/s0960-9822(09)00431-x · Cited by 2,783 · see citing works
Archives of Biochemistry and Biophysics
Carter, H. E., Bhattacharyya, P., Weidman, K. R., & Fraenkel, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06727.x · Cited by 1,895 · see citing works
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J. W., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,377 · see citing works
Structure and expression of a human oxytocin receptor
Kimura, T., Tanizawa, O., Mori, K., Brownstein, M., & Okayama, H. (1992) · Nature · doi:10.1038/356526a0 · Cited by 631 · see citing works
Palmitoylation of the human β2-adrenergic receptor
O’Dowd, B. F., Hnatowich, M. R., Caron, M. G., Lefkowitz, R. J., & Bouvier, M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83271-9 · Cited by 598 · see citing works
Molecular cloning of the receptor for human antidiuretic hormone
Birnbaumer, M., Seibold, A. M., Gilbert, S., Ishido, M., Barberis, C., Antaramián, A., Brabet, P., & Rosenthal, W. (1992) · Nature · doi:10.1038/357333a0 · Cited by 539 · see citing works
Self-citationMolecular Biology of Muscarinic Acetylcholine Receptors
Wess, J. (1996) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.40 · Cited by 491 · see citing works
Savarese, T. M., & Fraser, C. M. (1992) · Biochemical Journal · doi:10.1042/bj2830001 · Cited by 465 · see citing works
Michell, R. H., Kirk, C. J., & BILLAH, M. M. (1979) · Biochemical Society Transactions · doi:10.1042/bst0070861 · Cited by 440 · see citing works
Ovchinnikov, Y. A., Abdulaev, N. G., & Bogachuk, A. S. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80628-8 · Cited by 414 · see citing works
Vasopressin and oxytocin receptors in the central nervous system
Tribollet, E., & Barberis, C. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.60 · Cited by 399 · see citing works
Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.
Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S., & Kawashima, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47129-3 · Cited by 376 · see citing works
The role of adenosine 3′,5′-phosphate in the action of antidiuretic hormone
Orloff, J., & Handler, J. S. (1967) · The American Journal of Medicine · doi:10.1016/0002-9343(67)90093-9 · Cited by 348 · see citing works
Extrapituitary expression of the rat V1b vasopressin receptor gene.
Lolait, S. J., O’Carroll, A., Mahan, L. C., Felder, C. C., Button, D. C., Young, W. S., Mezey, É., & Brownstein, M. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6783 · Cited by 337 · see citing works
Thibonnier, M., Auzan, C., Madhun, Z. T., Wilkins, P. L., Berti‐Mattera, L. N., & Clauser, É. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41863-1 · Cited by 281 · see citing works
The Binding Site of Neuropeptide Vasopressin V1a Receptor
Mouillac, B., Chini, B., Balestre, M.-N., Elands, J., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Jard, S., & Barberis, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25771 · Cited by 262 · see citing works
Self-citationCloning and characterization of the human V3 pituitary vasopressin receptor
de Keyzer, Y., Auzan, C., Lenne, F., Beldjord, C., Thibonnier, M., Bertagna, X., & Clauser, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01268-7 · Cited by 209 · see citing works
Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase
Rosenthal, W., Antaramián, A., Gilbert, S., & Birnbaumer, M. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38614-4 · Cited by 185 · see citing works
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor
Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp‐Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., & Jard, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07211.x · Cited by 179 · see citing works
Self-citationWess, J., Nanavati, S., Vogel, Z., & Maggio, R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05661.x · Cited by 166 · see citing works
Carbachol and oxytocin stimulate the generation of inositol phosphates in the guinea pig myometrium
Marc, S., Leiber, D., & Harbon, S. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80561-0 · Cited by 162 · see citing works
X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.
Bichet, D. G., Arthus, M., Lonergan, M., Hendy, G. N., Paradis, A. J., Fujiwara, T., Morgan, K., Gregory, M. C., Rosenthal, W., & Didwania, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116698 · Cited by 147 · see citing works
Structural modifications of glycopeptide antibiotics
Malabarba, A., Nicas, T. I., & Thompson, R. C. (1997) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199701)17:1 · Cited by 140 · see citing works
Postina, R., Kojro, E., & Fahrenholz, F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31593 · Cited by 134 · see citing works
Liu, J., & Wess, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8772 · Cited by 133 · see citing works
Chini, B., Mouillac, B., Balestre, M.-N., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Andriolo, M., Pupier, S., Jard, S., & Barberis, C. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01135-0 · Cited by 117 · see citing works
Self-citationAla, Y., Morin, D., Mouillac, B., Sabatier, N., Vargas‐Poussou, R., de la Cotte, N., Déchaux, M., Antignac, C., Arthus, M., Lonergan, M., et al. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9101861 · Cited by 109 · see citing works
Self-citationManning, M., & Sawyer, W. H. (1993) · Journal of Receptor Research · doi:10.3109/10799899309073655 · Cited by 90 · see citing works
A fully active nonglycosylated V2 vasopressin receptor.
Innamorati, G., Sadeghi, H. M., & Birnbaumer, M. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09293-4 · Cited by 88 · see citing works
Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla
Grazzini, E., Lodboerer, A. M., Pérez‐Martin, A., BRESSION, D., & Guillon, G. (1996) · Endocrinology · doi:10.1210/endo.137.9.8756565 · Cited by 87 · see citing works
Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor
Kojro, E., Eich, P., Gimpl, G., & Fahrenholz, F. (1993) · Biochemistry · doi:10.1021/bi00212a020 · Cited by 78 · see citing works
Palmitoylation of the V2 Vasopressin Receptor
Hamid, M., Innamorati, G., Dagarag, M. D., & Birnbaumer, M. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.21 · Cited by 78 · see citing works
Molecular characterization of a cloned human oxytocin receptor
Kimura, T., Makino, Y., Saji, F., Takemura, M., Inoue, T., Kikuchi, T., Kubota, Y., Azuma, C., Nobunaga, T., Tokugawa, Y., et al. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310385 · Cited by 77 · see citing works
Birnbaumer, M. E., Gilbert, S., & Rosenthal, W. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.7.7984150 · Cited by 72 · see citing works
Briley, E. M., Lolait, S. J., Axelrod, J., & Felder, C. C. (1994) · Neuropeptides · doi:10.1016/0143-4179(94)90017-5 · Cited by 70 · see citing works
An extracellular residue determines the agonist specificity of V2 vasopressin receptors
Ufer, E., Postina, R., Gorbulev, V., & Fahrenholz, F. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00150-8 · Cited by 65 · see citing works
Model Systems For The Study Of Seven-Transmembrane-Segment Receptors
Dohlman, H. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.60.1.653 · Cited by 61 · see citing works
Phalipou, S., de la Cotte, N., Carnazzi, E., Seyer, R., Mahé, E., Jard, S., Barberis, C., & Mouillac, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26536 · Cited by 60 · see citing works
Self-citationMironneau, J. (1976) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf01062278 · Cited by 56 · see citing works
Hausmann, H., Richters, A., Kreienkamp, H., Meyerhof, W., Mattes, H., Lederis, K. P., Zwiers, H., & Richter, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6907 · Cited by 47 · see citing works
Howl, J., & Wheatley, M. (1996) · Biochemical Journal · doi:10.1042/bj3170577 · Cited by 34 · see citing works
Birnbaumer, M. E. (1994) · Molecular Endocrinology · doi:10.1210/me.8.7.886 · Cited by 30 · see citing works
Three Novel AVPR2 Mutations in Three Japanese Families with X-Linked Nephrogenic Diabetes Insipidus
Tajima, T., Nakae, J., Takekoshi, Y., Takahashi, Y., Yuri, K., Nagashima, T., & Fujieda, K. (1996) · Pediatric Research · doi:10.1203/00006450-199603000-00022 · Cited by 26 · see citing works
G protein coupling of human platelet V1 vascular vasopressin receptors
Thibonnier, M., Goraya, T., & Berti‐Mattera, L. N. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.5.c1336 · Cited by 26 · see citing works
Gopalakrishnan, V., McNeill, J. R., Sulakhe, P. V., et al. (1988) · Endocrinology · doi:10.1210/endo-123-2-922 · Cited by 25 · see citing works
A New Series of Photoactivatable and Iodinatable Linear Vasopressin Antagonists
Carnazzi, E., Aumelas, A., Barberis, C., et al. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00038a013 · Cited by 23 · see citing works
Self-citationTrumpp-Kallmeyer, S., Chini, B., Mouillac, B., Barberis, C., Hoflack, J., & Hibert, M. (1995) · Pharmaceutica Acta Helvetiae · doi:10.1016/0031-6865(95)00029-9 · Cited by 21 · see citing works
Self-citationPavo, I. J., & Fahrenholz, F. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80485-2 · Cited by 20 · see citing works
Jans, D. A., Jans, P., Luzius, H., et al. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90137-l · Cited by 16 · see citing works
Carnazzi, E., Aumelas, A., Phalipou, S., Mouillac, B., Guillon, G., Barberis, C., & Seyer, R. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00906.x · Cited by 12 · see citing works
Self-citationMendre, C., Dufour, M. N., Roux, S. L., Seyer, R., Guillou, L., Calas, B., & Guillon, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21027 · Cited by 11 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Eds H Imura & K Shizume. Amsterdam: Elsevier.
Cited by
Sorted by citations
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089 · see citing works
Physiology of Vasopressin Relevant to Management of Septic Shock
Holmes, C. L., Patel, B. M., Russell, J. A., & Walley, K. R. (2001) · Chest · doi:10.1378/chest.120.3.989 · Cited by 620 · see citing works
Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders?
CARTER, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.08.025 · Cited by 432 · see citing works
Israel, S., Lerer, E., Shalev, I., Uzefovsky, F., Riebold, M., Laiba, E., Bachner-Melman, R., Maril, A., Bornstein, G., Knafo, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005535 · Cited by 278 · see citing works
Vasopressin and disorders of water balance: the physiology and pathophysiology of vasopressin
Ball, S. G. (2007) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456307781646030 · Cited by 110 · see citing works
Vasopressin, oxytocin, and social odor recognition
Wacker, D. W., & Ludwig, M. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.08.014 · Cited by 112 · see citing works
Song, Z., Borland, J. M., Larkin, T. E., O’Malley, M., & Albers, H. E. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.09.001 · Cited by 101 · see citing works
Zhang, L., & Hernández, V. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.010 · Cited by 96 · see citing works
Crystal structure of the human oxytocin receptor
Waltenspühl, Y., Schöppe, J., Ehrenmann, J., Kummer, L., & Plückthun, A. (2020) · Science Advances · doi:10.1126/sciadv.abb5419 · Cited by 95 · see citing works
Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects
Rae, M., Lemos Duarte, M., Gomes, I., Camarini, R., & Devi, L. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15481 · Cited by 72 · see citing works
Neuropeptide diversity and the regulation of social behavior in New World primates
French, J. A., Taylor, J. H., Mustoe, A. C., & Cavanaugh, J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.03.004 · Cited by 66 · see citing works
Vargas-Pinilla, P., Paixão-Côrtes, V. R., Paré, P., Tovo-Rodrigues, L., Vieira, C. M. D. A. G., Xavier, A., Comas, D., Pissinatti, A., Sinigaglia, M., Rigo, M. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419399112 · Cited by 59 · see citing works
Chan, W. Y., Wo, N. C., Stoev, S., Cheng, L. L., & Manning, M. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00003.x · Cited by 41 · see citing works
Ren, D., Chin, K. R., & French, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111638 · Cited by 28 · see citing works
Oxytocin, vasopressin and their interplay with gonadal steroids
Dhakar, M. B., Stevenson, E. L., & Caldwell, H. K. (2013) · Oxytocin, Vasopressin and Related Peptides in the Regulation of Behavior · doi:10.1017/cbo9781139017855.003 · Cited by 20 · see citing works
- Authors
- Barberis, C., Mouillac, B., & Durroux, T.
- Affiliations
- Inserm (FR)
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 1998-02-01
- Volume
- 156
- Issue
- 2
- Pages
- 223-229
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2096250412
- Cited by
- 311
- References
- 51
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 7 · 2017: 6 · 2016: 19 · 2015: 6 · 2014: 13 · 2013: 17 · 2012: 11
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- vasopressin receptor, oxytocin receptor, vasopressin, neurohypophyseal hormones, receptor structure, V1a receptor, V1b receptor, V2 receptor, receptor classification, peptide analogues, second messenger signaling, G protein-coupled receptors, cyclic AMP, cyclic GMP, protein kinase A, protein kinase C
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Protein Binding, Signal Transduction, Receptors, Vasopressin, Receptors, Oxytocin, GTP-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
